Skip to content

LLETZ Under Direct Colposcopic Vision

Direct Colposcopic Vision and Large Loop Excision of the Transformation Zone in Women With Cervical Dysplasia: a Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02910388
Enrollment
150
Registered
2016-09-22
Start date
2016-10-31
Completion date
2017-12-31
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Dysplasia

Keywords

conization, LLETZ, loop excision, randomized controlled trial, colposcopy, direct colposcopic vision, intraoperative colposcopy

Brief summary

To assess the benefits of large Loop excision of the transformation Zone (LLETZ) under direct colposcopic Vision.

Interventions

DEVICELLETZ with colposcopy

Loop procedure using a colposcope in order to see and remove the abnormal cervical tissue

OTHERLLETZ without colposcopy

Loop procedure without using a colposcope

Sponsors

Ruhr University of Bochum
CollaboratorOTHER
Zydolab - Institute of Cytology and Immune Cytochemistry
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* histologically proven cervical dysplasia * colposcopy Prior to conization * informed consent

Exclusion criteria

* significant language barrier * a personal history of conization * pregnancy * the use of blood thinner * unwillingness to participate

Design outcomes

Primary

MeasureTime frameDescription
the resected cone mass10 minutesthe resected cone mass will be quantified by weighing the removed tissue with a precision scale located in the operating room

Secondary

MeasureTime frameDescription
number of fragments of the surgical specimen10 minutessurgeons will count the number of the surgical specimen (1 vs. \>1)
the dimensions of the surgical specimens2 Days after conizationThe circumference, length and thickness of The surgical specimens will be measured
Margin status2 Days after conizationResection margin is judge as R0 if abnormal cells are not found in the margin of the biopsy or R1 if abnormal cells remain in the margin of the biopsy. The histopathological examination will be done by an Independent pathologist
Operation time20 minutesthe time from the beginning of the Operation (start of the electrosurgical method) until the end of the operation (the end of hemostatic interventions) will be measured in minutes
Operative complications14 daysOperative complications defined as necessity to intervene therapeutically up to 14 days postoperatively
satisfaction with the device30 minutessurgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,satisfaction with the device' (ranging from 0 (,very satisfied') to 10 (,absolutely not satisfied')
Time to complete intraoperative hemostasis120 secondsthe time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds
Intraoperative blood loss5 hoursintraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively
handling of the device30 minutessurgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,(ranging from 0 (,very easy') to 10 (,very difficult')

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026